Article Text

Download PDFPDF
Admission to hospital in the UK at a weekend does not influence the prognosis of adults with community-acquired pneumonia
  1. Hannah Lawrence1,2,
  2. Tricia M McKeever2,
  3. Wei Shen Lim1
  4. on behalf of British Thoracic Society
  1. 1 Respiratory Medicine, Nottingham City Hospital, Nottingham, UK
  2. 2 Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK
  1. Correspondence to Dr Hannah Lawrence, Respiratory Medicine, Nottingham City Hospital, Nottingham NG5 1PB, UK; hannah.lawrence1{at}nottingham.ac.uk

Abstract

Outcomes for adults with community-acquired pneumonia (CAP) admitted to hospital at the weekend were compared with those admitted during weekdays using data from the British Thoracic Society national CAP audits. Of 31 400 cases, 40.7% were weekend admissions; these patients were older (mean age 72 vs 71.3 years, p=0.001) and more likely to have high severity CAP (28.9% vs 27.1%, p trend 0.003) but had slightly lower adjusted 30-day inpatient mortality (aOR 0.94 95% CI 0.88 to 1.01) compared with those admitted during weekdays. More patients in the weekend group received antibiotics within 4 hours of admission (70.3% vs 68.7%, aOR 1.07 95% CI 1.01 to 1.12). We did not observe increased mortality for adults admitted at the weekend with CAP.

  • pneumonia

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Collaborators To ensure members/collaborators of "British Thoracic Society" are citable in PubMed please ensure individuals are listed in the "Collaborators" section.

  • Contributors HL, WSL and TM provided the analysis for the draft paper. All authors were involved in drafting and approving the final paper for publication.

  • Funding This work is supported by NIHR Nottingham BRC.

  • Competing interests WSL’s institution has received unrestricted investigator-initiated research funding from Pfizer for an unrelated multicentre study for which WSL is chief investigator.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.